Biotech Business - April 22, 2025
Zelluna reaches milestone – Manufacturing process established
Zelluna has developed, scaled and automated its manufacturing process for its TCR-NK cell therapies.
Biotech Business - April 15, 2025
EU approves Leqembi for treatment of early Alzheimer’s disease
The European Commission has granted BioArctic’s partner Eisai’s application for Marketing Authorization of Leqembi (lecanemab) in the European Union (EU).
Biotech Business - April 15, 2025
Nykode’s CEO, CSO and CFO have withdrawn their resignations
Nykode announces that Michael Engsig, CEO, Agnete Fredriksen, CSO & Co-founder, and Harald Gurvin, CFO, have withdrawn their recent resignations and will continue with Nykode.
Biotech Business - April 9, 2025
TIRmed Pharma raises EUR 4.3 million
The company has raised financing in a funding round led by Sciety and Sciety Venture Partners.
Biotech Business - April 4, 2025
Orion to open Biologics R&D Centre in Cambridge
Orion Corporation has announced that it is establishing a new research & development centre in Cambridge, UK during 2025 to accelerate its global growth strategy and the development of innovative medicines.
Biotech Business - April 4, 2025
Akiram Therapeutics announces Eurostars-funded collaboration
The company has announced the launch of the research project PRE-CISE in collaboration with Danish companies PreTT and TetraKit Technologies.
